Condition: Non-Alcoholic Steatohepatitis(NASH) · Hepatitis C · Hepatitis B · Sponsor: State University of New York at Buffalo
The purpose of establishing a biorepository is to provide high quality specimens (serum, plasma, buffy coat and liver tissue) for future researchers who are studying the effects that fatty liver and viral diseases have on the liver.
This description comes directly from the study's public registry record.
Barbara Bauer, BA · 716-888-4825 · bmbauer@buffalo.edu
Always discuss trial participation with your own doctor first.
| University at Buffalo, Buffalo General Medical Center | Buffalo, New York, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03025074